litlas
Log inCreate account

Barbara Burtness

Active 1996–2025

138
Papers
30,312
Citations
75
h-index
131
i10-index

Citations

Citations per year for Barbara Burtness1995: 3 citations1997: 1 citations1998: 4 citations1999: 4 citations2000: 9 citations2001: 25 citations2002: 30 citations2003: 34 citations2004: 28 citations2005: 38 citations2006: 57 citations2007: 63 citations2008: 47 citations2009: 41 citations2010: 44 citations2011: 49 citations2012: 45 citations2013: 61 citations2014: 59 citations2015: 71 citations2016: 110 citations2017: 228 citations2018: 204 citations2019: 919 citations2020: 1,301 citations2021: 1,520 citations2022: 1,375 citations2023: 995 citations2024: 1,847 citations2025: 905 citations2026: 18 citations1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,723 citing papers, 25.5% of this breakdownChina: 1,783 citing papers, 16.7% of this breakdownGermany: 547 citing papers, 5.1% of this breakdownItaly: 505 citing papers, 4.7% of this breakdownUnited Kingdom: 455 citing papers, 4.3% of this breakdownJapan: 399 citing papers, 3.7% of this breakdownFrance: 368 citing papers, 3.4% of this breakdownCanada: 356 citing papers, 3.3% of this breakdownSpain: 283 citing papers, 2.6% of this breakdownIndia: 268 citing papers, 2.5% of this breakdownAustralia: 266 citing papers, 2.5% of this breakdownNetherlands: 233 citing papers, 2.2% of this breakdown
0%25.5%Other 23.5%

Institutions

Fields

  • Medicine72.1%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Immunology and Microbiology4.7%
  • Engineering1.6%
  • Dentistry1%
  • Computer Science0.6%
  • Other2.6%

Topics

  • Head and Neck Cancer Studies10.4%
  • Cancer Immunotherapy and Biomarkers10.1%
  • Esophageal Cancer Research and Treatment3%
  • Immunotherapy and Immune Responses2.7%
  • Lung Cancer Treatments and Mutations2.6%
  • Radiomics and Machine Learning in Medical Imaging1.8%
  • Other69.4%

Coauthors

All papers

Open in search
  1. Head and neck squamous cell carcinoma

    Authors: Daniel E. Johnson, Barbara Burtness, C. René Leemans, Vivian Wai Yan Lui, Julie E. Bauman, Jennifer R. Grandis - Nature Reviews Disease Primers 2020 cited by 4,029

  2. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

    Authors: Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey‐Long Hong, René González Mendoza, Ananya Roy, Yayan Zhang, Burak Gümüşçü, Jonathan D. Cheng, Fan Jin, Danny Rischin, Guillermo Lerzo, Marcelo Tatangelo, Mirta Varela, Juan José Zarbá, Michael Boyer, Hui Gan, Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi and 119 more - The Lancet 2019 cited by 3,211

  3. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

    Authors: Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau, José Dinis, Lisa Licitra, Myung‐Ju Ahn, Ainara Soria, Jean‐Pascal Machiels, Nicolas Mach, Ranee Mehra, Barbara Burtness, Pingye Zhang, Jonathan D. Cheng, Ramona F. Swaby, Kevin J. Harrington, Mirelis Acosta-Rivera, Douglas R. Adkins, Morteza Aghmesheh, Myung‐Ju Ahn, Mario Airoldi, Eduardas Aleknavičius, Yousuf Al-Farhat, Alain P. Algazi, Salah Almokadem, Anna Alyasova, Jessica R. Bauman, Marco Benasso, Alfonso Berrocal, Victoria Bray, Barbara Burtness, Francesco Caponigro, Ana Castro, Terrence P. Cescon, Kelvin Chan, Arvind Chaudhry, Bruno Chauffert, Ezra E.W. Cohen, Tibor Csőszi, Jan Paul de Boer, Jean‐Pierre Delord, Andreas Dietz, José Dinis, Charlotte Dupuis, Laurence Digue, József Erfán, Yolanda Escobar Alvarez, Mererid Evans, Mary J. Fidler, Martin Förster, Signe Friesland, Apar Kishor Ganti, Lionnel Geoffrois, Clíona Grant, Viktor Gruenwald, Kevin J. Harrington, Thomas K. Hoffmann, Geza Horvai, Arturas Inčiūra, Raymond Woo-Jun Jang, Petra Jankowska, Antonio Jimeno, Mano Joseph, Alejandro Juárez Ramiro, Bogusława Karaszewska, Andrzej Kawecki, Ulrich Keilholz, Ulrich Keller, Sung‐Bae Kim, Judit Kocsis, Nuria Kotecki, Mark Kozloff, J. Lambea, László Landherr, Yuri Lantsukhay, Sergey Lazarev, Lip Way Lee, Christophe Le Tourneau, Lisa Licitra, Igor Lifirenko, Nicolas Mach, Danko Martincic, О. В. Маторин, Margaret McGrath, Jean‐Pascal Machiels, Ranee Mehra, Krzysztof Misiukiewicz, John C. Morris, Ф. Ф. Муфазалов, Jiaxin Niu, Devraj Srinivasan, Pedro Pérez Segura, Daniel Rauch, Maria Leonor Ribeiro, Cristina P. Rodriguez, Frédéric Rolland, Antonio Russo, Ágnes Ruzsa, Frederico Sanches, Sangwon Shin, Mikhail Shtiveland and 13 more - The Lancet 2018 cited by 1,697

  4. Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study

    Authors: Kevin J. Harrington, Barbara Burtness, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Irene Braña, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gümüşçü, Ramona F. Swaby, Danny Rischin - Journal of Clinical Oncology 2022 cited by 490

  5. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

    Authors: Tanguy Y. Seiwert, Barbara Burtness, Ranee Mehra, Jared Weiss, Raanan Berger, Joseph P. Eder, Karl Heath, Terrill K. McClanahan, Jared Lunceford, Christine K. Gause, Jonathan D. Cheng, Laura Q.M. Chow - The Lancet Oncology 2016 cited by 1,740

  6. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

    Authors: Maura L. Gillison, Andy Trotti, Jonathan Harris, Avraham Eisbruch, Paul M. Harari, David J. Adelstein, Richard C. Jordan, Weiqiang Zhao, Erich M. Sturgis, Barbara Burtness, John A. Ridge, Jolie Ringash, James M. Galvin, Min Yao, Shlomo A. Koyfman, Dukagjin Blakaj, Mohammed A. Razaq, A. Dimitrios Colevas, Jonathan J. Beitler, Christopher U. Jones, Neal Dunlap, Samantha A. Seaward, Sharon A. Spencer, Thomas J. Galloway, Jack Phan, James J. Dignam, Quynh‐Thu Le - The Lancet 2018 cited by 1,295

  7. The changing therapeutic landscape of head and neck cancer

    Authors: John D. Cramer, Barbara Burtness, Quynh‐Thu Le, Robert L. Ferris - Nature Reviews Clinical Oncology 2019 cited by 812

  8. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

    Authors: Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco, Barbara Burtness, Maura L. Gillison, Kevin J. Harrington, Quynh‐Thu Le, Nancy Y. Lee, Rom S. Leidner, Rebecca Lewis, Lisa Licitra, Hisham Mehanna, Loren K. Mell, Adam Raben, Andrew G. Sikora, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg, Robert L. Ferris - Journal for ImmunoTherapy of Cancer 2019 cited by 738

  9. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

    Authors: Robert L. Ferris, Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra, Joaquin J. Garcia, Christine H. Chung, Maura L. Gillison, Umamaheswar Duvvuri, Bert W. O'Malley, Enver Ozer, Giovana R. Thomas, Wayne M. Koch, Neil D. Gross, R. Bryan Bell, Nabil F. Saba, Miriam Lango, Eduardo Méndez, Barbara Burtness - Journal of Clinical Oncology 2021 cited by 441

  10. STING enhances cell death through regulation of reactive oxygen species and DNA damage

    Authors: Thomas J. Hayman, Marta Baro, Tyler MacNeil, Chatchai Phoomak, Thazin Nwe Aung, Wei Cui, Kevin Leach, Radhakrishnan P. Iyer, Sreerupa Challa, Teresa Sandoval-Schaefer, Barbara Burtness, David L. Rimm, Joseph N. Contessa - Nature Communications 2021 cited by 207

  11. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012

    Authors: Ranee Mehra, Tanguy Y. Seiwert, Shilpa Gupta, Jared Weiss, Iris Gluck, Joseph P. Eder, Barbara Burtness, Makoto Tahara, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Ravit Geva, Hyun Cheol Chung, Chia‐Chi Lin, Deepti Aurora-Garg, Archana Ray, Kumudu Pathiraja, Jonathan D. Cheng, Laura Q.M. Chow, Robert I. Haddad - British Journal of Cancer 2018 cited by 456

  12. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

    Authors: Kei Muro, Hyun Cheol Chung, Veena Shankaran, Ravit Geva, Daniel V.T. Catenacci, Shilpa Gupta, Joseph P. Eder, Talia Golan, Dung T. Le, Barbara Burtness, Autumn J. McRee, Chia‐Chi Lin, Kumudu Pathiraja, Jared Lunceford, Kenneth Emancipator, Jonathan Juco, Minori Koshiji, Yung‐Jue Bang - The Lancet Oncology 2016 cited by 1,131

  13. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

    Authors: Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra, Barbara Burtness, Makoto Tahara, Danny Rischin, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Brett Hughes, Y. Pointreau, Sercan Aksoy, Simon Laban, Richard Greil, Martin Burian, Marcin Hetnał, Jean‐Pierre Delord, Ricard Mesı́a, Miren Taberna, John Waldron, Christian Simon, Vincent Grégoire, Kevin J. Harrington, Ramona F. Swaby, Yayan Zhang, Burak Gümüşçü, Behzad Bidadi, Lillian L. Siu, Danny Rischin, Brett Hughes, Bo Gao, Margaret McGrath, Richard Greil, Dietmar Thurnher, Thorsten Fuereder, Martin Burian, Sylvie Rottey, Jean‐Pascal Machiels, Paul Clement, Stéphanie Henry, S. Deheneffe, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Josiane Mourão Dias, Pedro Rafael Martins De Marchi, Milena Perez Mak, Andrea Juliana Gomes, Dalvaro Oliveira de Castro Junior, Tatiane Cardoso Motta, Mônica Luciana Agostinho Padoan, Ana Paula Victorina, Sérgio Jobim Azevedo, Lillian L. Siu, Stephanie Yasmin Brule, John Hilton, Chang Shu Wang, Nathaniel Bouganim, Marc Webster, John Walker, Neil Chua, Ángela R. Zambrano, Alicia Quiroga Echeverri, Oscar Mauricio Niño Gomez, Carlos Alberto Ortiz, Luis Alejandro Rojas, Andrés Cardona Zorilla, Olga Marcela Urrego Meléndez, Petra Holečková, Bohuslav Melichar, Jakub Cvek, Jana Prausová, Milan Vošmik, Jean‐Pierre Delord, Xavier Zasadny, Lionnel Geoffrois, Yungan Tao, Y. Pointreau, Rainer Fietkau, Marlen Haderlein, Andreas Müller, Ursula C. Schroeder, Barbara Wollenberg, Simon Laban, Philipp Ivanyi, Viktor Gruenwald, Philippe Schafhausen, Orit Gutfeld, Iris Gluck, Aron Popovtzer, Amichay Meirovitz, Salem Billan, Baruch Brenner, Aron Popovtzer, Dror Limon, Lisa Licitra, Francesco Perri, Francesco Caponigro, Martina Violati, Daris Ferrari, Franco Nolè, Federica Bertolini and 90 more - The Lancet Oncology 2024 cited by 210

  14. Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update

    Authors: Aarti Bhatia, Barbara Burtness - Drugs 2023 cited by 210

  15. Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score

    Authors: Barbara Burtness, Danny Rischin, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro Jr, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G.M. Hughes, Ricard Mesia, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Joy Ge, Ramona F. Swaby, Burak Gumuscu, Kevin Harrington - Journal of Clinical Oncology 2022 cited by 207

  16. Pembrolizumab alone or with chemotherapy for recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by Programmed Death Ligand-1 combined positive score

    Authors: Barbara Burtness, Danny Rischin, Richard Greil, Denis Soulières, Makoto Tahara, Castro, Gilberto de, Amanda Psyrri, Irene Braña, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Mesía Nin, Ricard, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Joy Yang Ge, Ramona F. Swaby, Burak Gümüşçü, Kevin J. Harrington - 2022 cited by 177

  17. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

    Authors: Laura Q.M. Chow, Robert I. Haddad, Shilpa Gupta, Amit Mahipal, Ranee Mehra, Makoto Tahara, Raanan Berger, Joseph P. Eder, Barbara Burtness, Se‐Hoon Lee, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Jared Weiss, Ravit Geva, Chia‐Chi Lin, Hyun Cheol Chung, Amy Meister, Marisa Dolled‐Filhart, Kumudu Pathiraja, Jonathan D. Cheng, Tanguy Y. Seiwert - Journal of Clinical Oncology 2016 cited by 859

  18. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

    Authors: Benjamin Lacas, Alexandra Carmel, C. Landais, Stuart J. Wong, Lisa Licitra, Jeffrey Tobias, Barbara Burtness, Maria Grazia Ghi, Ezra E.W. Cohen, Cai Grau, Gregory T. Wolf, Ricardo Hitt, Renzo Corvò, Volker Budach, Shaleen Kumar, Sarbani Ghosh Laskar, Jean‐Jacques Mazeron, Lai‐ping Zhong, W. Dobrowsky, Pirus Ghadjar, C. Fallai, Branko Zakotnik, Atul Sharma, René‐Jean Bensadoun, Maria Grazia Ruo Redda, S. Racadot, George Fountzilas, David M. Brizel, P Rovea, Athanassios Argiris, Zoltán Takácsi Nagy, Ju‐Whei Lee, Catherine Fortpied, Jonathan Harris, Jean Bourhis, Anne Aupérin, Pierre Blanchard, Jean‐Pierre Pignon, David J. Adelstein, M. Alfonsi, Y. Belkacemi, Voichita Bar‐Ad, J. Bernier, Åse Bratland, G. Calais, Brittany Campbell, Jimmy J. Caudell, Sylvie Chabaud, Emmanuel Chamorey, Devendra Chaukar, Kwang Nam Choi, Olivier Choussy, Laurence Collette, Judith Cruz, Carla Dani, Etienne Dauzier, Arlene A. Forastiere, P. Garaud, V. Grégoire, A. Hackshaw, E. Haddad, Bruce G. Haffty, Aaron R. Hansen, Stefanie Hayoz, Jean-Claude Horiot, Branislav Jeremić, Theodore Karrison, Johannes A. Langendijk, M. Lapeyre, Éric Lartigau, Traci Leong, Quynh‐Thu Le, Patricia Lee, Freddi Lewin, Aihua Lin, Alberto Lopes, Samir Mehta, James Moon, Elizabeth Moyal, Bob‐Valéry Occéan, P. Olmi, Roberto Orecchia, Brian O’Sullivan, Jens Overgaard, Claire Petit, Harvey Quon, Giuseppe Sanguineti, Tuvana Satar, John Simes, Christian Simon, Clément Sire, S. Staar, C. Stromberger, P. Strojan, Stéphane Temam, David Thomson, A. Timochenko, Valter Torri, Vassilikì Tseroni, Jan B. Vermorken and 5 more - Radiotherapy and Oncology 2021 cited by 376

  19. Immunotherapy for head and neck cancer: Recent advances and future directions

    Authors: John D. Cramer, Barbara Burtness, Robert L. Ferris - Oral Oncology 2019 cited by 305

  20. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

    Authors: Shanthi Marur, Shuli Li, Anthony J. Cmelak, Maura L. Gillison, Weiqiang Zhao, Robert L. Ferris, William H. Westra, Jill Gilbert, Julie E. Bauman, Lynne I. Wagner, David R. Trevarthen, Jahagirdar Balkrishna, Barbara A. Murphy, Nishant Agrawal, A. Dimitrios Colevas, Christine H. Chung, Barbara Burtness - Journal of Clinical Oncology 2017 cited by 504

  21. Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks

    Authors: Benjamin H. Kann, Sanjay Aneja, Gokoulakrichenane Loganadane, Jacqueline Kelly, Stephen J. Smith, Roy H. Decker, James B. Yu, Henry S. Park, Wendell G. Yarbrough, Ajay Malhotra, Barbara Burtness, Zain Husain - Scientific Reports 2018 cited by 207

  22. LBA5 Primary results of the phase III KEYNOTE-412 study: Pembrolizumab (pembro) with chemoradiation therapy (CRT) vs placebo plus CRT for locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)

    Authors: J-P. Machiels, Yungan Tao, Barbara Burtness, M. Tahara, D. Rischin, G.V. Alves, I.P. Figueiredo Lima, B.G.M. Hughes, Y. Pointreau, S. Aksoy, Simon Laban, R. Greil, M. Burian, M. Hetnal, L.F. Licitra, R. Swaby, Y. Zhang, B. Gumuscu, B. Bidadi, L.L. Siu - Annals of Oncology 2022 cited by 91

  23. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer

    Authors: Julie E. Bauman, Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia, Jameel Muzaffar, Ricklie Julian, Steven Wang, Shethal Bearelly, Audrey Z. Baker, Conor Steuer, Anshu Giri, Barbara Burtness, Sara Centuori, Carlos Caulı́n, Robert J. Klein, Kathylynn Saboda, Stefanie Obara, Christine H. Chung - Journal of Clinical Oncology 2023 cited by 48

  24. Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation

    Authors: Xiaojia Guo, Leyuan Xu, Heino Velázquez, Tian-Min Chen, Ryan M. Williams, Daniel A. Heller, Barbara Burtness, Robert Safirstein, Gary V. Désir - Journal of the American Society of Nephrology 2021 cited by 65